Liminatus Pharma Warrants Operating Income

Track Liminatus Pharma Warrants's operating income ($-3.1B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-1020000.00

As of Sep 30, 2024

Annual Operating Income (TTM)

$-3119128746.00

Trailing 12 months ending Sep 30, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin

Liminatus Pharma Warrants (LIMNW) FAQ

As of the most recent data (September 2024), LIMNW shows a operating income of $-3.1B. Scroll down for historical charts and peer comparison views.

Tracking LIMNW's operating income over time shows whether Liminatus Pharma Warrants is scaling, shrinking, or reshaping that part of the business. The current reading is $-3.1B Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Liminatus Pharma Warrants's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-3.1B) with ownership activity and broader fundamentals.